The antibody response to oligodendrocyte specific protein in multiple sclerosis

Journal of Neuroimmunology

Volumn 221, Issue 1-2, 2010, Pages 81-86

  Aslam, Muhammad ^a   Kalluri, Sudhakar Reddy ^a   Cepok, Sabine ^a   Kraus, Verena ^a   Buck, Dorothea ^a   Srivastava, Rajneesh ^a   Hemmer, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoantibody response; Multiple sclerosis; Oligodendrocyte specific protein

Indexed keywords

AUTOANTIBODY; CLAUDIN 11; CLDN11 PROTEIN, HUMAN; NERVE PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELL ASSAY; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLIA CELL; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; SCHOOL CHILD; WESTERN BLOTTING; ANTIBODY PRODUCTION; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; OLIGODENDROGLIA; PATHOLOGY; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 77951237949     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.02.008     Document Type: Article

References (24)

1. Bajramovic J.J., Brok H.P.M., Ouwerling B., Jagessar S.A., van Straalen L., Kondova I., Bauer J., Amor S., t Hart B.A., Ben-Nun A. Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve. Eur. J. Immunol. 2008, 38:1452-1464.
2. Breithaupt C., Schäfer B., Pellkofer H., Huber R., Linington C., Jacob U. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. J. Immunol. 2008, 181:1255-1263.
3. Brilot F., Dale R.C., Selter R.C., Grummel V., Kalluri S.R., Aslam M., Busch V., Zhou D., Cepok S., Hemmer B. Antibodies to native MOG in children with inflammatory demyelinating disease. Ann. Neurol. 2009, 66:833-842.
4. Bronstein J.M., Lallone R.L., Seitz R.S., Ellison G.W., Myers L.W. A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic. Neurology 1999, 53:154-161.
5. Gow A., Southwood C.M., Li J.S., Pariali M., Riordan G.P., Brodie S.E., Danias J., Bronstein J.M., Kachar B., Lazzarini R.A. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 1999, 99:649-659.
6. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2008, 358:676-688.
7. Kaushansky N., Zhong M.-C., Kerlero de Rosbo N., Hoeftberger R., Lassmann H., Ben-Nun A. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J. Immunol. 2006, 177:7364-7376.
8. Keegan M., König F., McClelland R., Brück W., Morales Y., Bitsch A., Panitch H., Lassmann H., Weinshenker B., Rodriguez M., Parisi J., Lucchinetti C.F. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005, 366:579-582.
9. Lassmann H., Raine C.S., Antel J., Prineas J.W. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J. Neuroimmunol. 1998, 86:213-217.
10. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
11. McLaughlin K.A., Chitnis T., Newcombe J., Franz B., Kennedy J., McArdel S., Kuhle J., Kappos L., Rostasy K., Pohl D., Gagne D., Ness J.M., Tenembaum S., O'Connor K.C., Viglietta V., Wong S.J., Tavakoli N.P., de Seze J., Idrissova Z., Khoury S.J., Bar-Or A., Hafler D.A., Banwell B., Wucherpfennig K.W. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 2009, 183:4067-4076.
12. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
13. O'Connor K., McLaughlin K., De Jager P., Chitnis T., Bettelli E., Xu C., Robinson W., Cherry S., Bar-Or A., Banwell B., Fukaura H., Fukazawa T., Tenembaum S., Wong S., Tavakoli N., Idrissova Z., Viglietta V., Rostasy K., Pohl D., Dale R., Freedman M., Steinman L., Buckle G., Kuchroo V., Hafler D., Wucherpfennig K. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Advanced online publication. Nat. Med. 2007, 13:211-217.
14. Paul F., Jarius S., Aktas O., Bluthner M., Bauer O., Appelhans H., Franciotta D., Bergamaschi R., Littleton E., Palace J., Seelig H.-P., Hohlfeld R., Vincent A., Zipp F. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007, 4:e133.
15. Reindl M., Khalil M., Berger T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 2006, 180:50-62.
16. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
17. Steinman L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2001, 2:762-764.
18. Storch M.K., Piddlesden S., Haltia M., Iivanainen M., Morgan P., Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 1998, 43:465-471.
19. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., Watanabe S., Shiga Y., Kanaoka C., Fujimori J., Sato S., Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
20. Tiwari-Woodruff S.K., Myers L.W., Bronstein J.M. Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration. J. Neurosci. Res. 2004, 77:363-366.
21. + channel KV3.1 associates with OSP/claudin-11 and regulates oligodendrocyte development. Am. J. Physiol. Cell. Physiol. 2006, 291:687-698.
22. von Büdingen H.-C., Hauser S.L., Fuhrmann A., Nabavi C.B., Lee J.I., Genain C.P. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8207-8212.
23. Weinshenker B.G., O'Brien P.C., Petterson T.M., Noseworthy J.H., Lucchinetti C.F., Dodick D.W., Pineda A.A., Stevens L.N., Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 1999, 46:878-886.
24. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Brück W., Hartung H.-P., Stadelmann C., Hemmer B. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19057-19062.